Switch For Brain’s Natural Anti-Oxidant Defense Identified By Scientists: Implications For Alzheimer’s, Parkinson’s And Other Brain Diseases0
Switch For Brain’s Natural Anti-Oxidant Defense Identified By Scientists: Implications For Alzheimer’s, Parkinson’s And Other Brain Diseases
Scientists at Dana-Farber Cancer Institute report they have found how the brain turns on a system designed to protect its nerve cells from toxic “free radicals,” a waste product of cell metabolism that has been implicated in some degenerative brain diseases, heart attacks, strokes, cancer, and aging. [click link for full article]
Researchers Use Novel 3D Imaging To Track Alzheimer’s
Using an innovative three-dimensional imaging technique, a team of UCLA researchers have tracked how Alzheimer’s disease spreads through the hippocampus - the area of the brain linked with memory - in a pattern consistent with the known trajectory of neurofibrilliary tangle dissemination, an accumulation of diseased proteins in the brain cells. [click link for full article]
Martek’s DHA Selected For NIH-Funded Alzheimer’s Study
Martek Biosciences (Nasdaq: MATK) announced today that its vegetarian source of DHA (docosahexaenoic acid) omega-3 derived from microalgae was the only DHA source selected for use in an upcoming multi-million dollar National Institutes of Health (NIH)-funded study on the effects of DHA in slowing the progression of Alzheimer’s disease. [click link for full article]
Research Team Identifies Human ‘memory Gene’
Researchers at the Translational Genomics Research Institute (TGen) announced on 19 Oct 2006 the discovery of a gene that plays a significant role in memory performance in humans. The findings, reported by TGen and research colleagues at the University of Zurich in Switzerland, Banner Alzheimer’s Institute, and Mayo Clinic Scottsdale, appear in the October 20 issue of Science. [click link for full article]
Memory Pharmaceuticals Provides Update On Phase 2a Trial Of MEM 3454 In Alzheimer’s Disease
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced an update on the investigational new drug application (IND) filed in September 2006 with the U.S. Food and Drug Administration (FDA) for MEM 3454. [click link for full article]
Novel Three-Dimensional Imaging Technique Used By Researchers
FINDINGS: Using an innovative three-dimensional imaging technique, a team of UCLA researchers have tracked how Alzheimer’s disease spreads through the hippocampus — the area of the brain linked with memory — in a pattern consistent with the known trajectory of neurofibrilliary tangle dissemination, an accumulation of diseased proteins in the brain cells. [click link for full article]
Devoted to Seniors: Supervisor of programs gives freely, honing skills working with her own mom
Edith Bailey’s day job is helping seniors play. As the supervisor for the Winston-Salem Recreation and Parks Department’s programs for seniors, she spends weekdays organizing and running such weekly and monthly …
Comment
U.S. Food And Drug Administration Approves ARICEPT(R) For Treatment Of Severe Alzheimer’s Disease
Eisai and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for ARICEPT(R) (donepezil HCl tablets) for treatment of severe Alzheimer’s disease (AD). The application was submitted by Eisai Medical Research Inc. (Headquarters: Ridgefield Park, President Mindell Seidlin, MD) on behalf of Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO Haruo Naito) and Eisai Inc. [click link for full article]